Impactiviti recently interviewed Jim DeMaioribus, Senior Director, Healthcare Strategy for Johnson & Johnson Healthcare systems, on the topic of Future Trends in Pharma Commercialization. Jim …
Pharma News 8_17
Amgen finally feels the heat from declining market demand; big cuts coming. Novartis takes a hit on Prexige (COX-2 inhibitor); withdrawn in Australia. New cancer killers? Electric fields, gene …
The J&J / Red Cross Tiff – Principle, or Pragmatism?
The recent legal spat between the American Red Cross (ARC) and Johnson and Johnson (J&J) (back story here, with more reportage and comment here, here, and here) brings to the surface a very …
Continue Reading about The J&J / Red Cross Tiff – Principle, or Pragmatism? →
How to get Entangled in a No-win Situation: J&J sues the Red Cross
I can just imagine the beating Johnson and Johnson will take over this one. After long negotiations got nowhere, J&J is suing the venerable Red Cross over the commercial use of the red cross …
Continue Reading about How to get Entangled in a No-win Situation: J&J sues the Red Cross →